KUALA LUMPUR: Pharmaniaga Bhd
announced that Bursa Malaysia has approved the group’s regularisation plan (RP), marking a significant milestone in Pharmaniaga’s journey towards financial recovery and long-term business sustainability.
Pharmaniaga managing director Zulkifli Jafar said the approval from Bursa Malaysia paves the way for Pharmaniaga to implement its comprehensive RP, designed to strengthen the group’s financial position, enhance operational efficiencies and secure long-term growth.
"With this latest development, we are now fully focused on executing the RP and achieving a swift exit from PN17,” he said in a statement today.
Zulkifli said the group assures its stakeholders, including customers, investors and business partners, that Pharmaniaga remains committed to maintaining the highest standards of service and product quality throughout this period of transformation.
The RP approval serves as a significant boost for the group, after recently reported its improved financial performance for the third quarter ended Sept 30, 2024. - Bernama
